You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

Profile for South Korea Patent: 20150090264


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20150090264

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 20, 2028 Abbvie VRAYLAR cariprazine hydrochloride
⤷  Start Trial Dec 16, 2028 Abbvie VRAYLAR cariprazine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Drug Patent KR20150090264

Last updated: August 3, 2025


Introduction

Patent KR20150090264, granted in South Korea, pertains to a novel pharmaceutical formulation or compound—specific details of which are critical for understanding its scope and landscape. As regulatory authorities like the Korean Intellectual Property Office (KIPO) scrutinize patent claims to define infringement boundaries and innovation boundaries, a comprehensive analysis provides insight into its legal strength, commercial potential, and competitive positioning.

This review dissects the patent's scope—focusing on claims, their language, and scope—and evaluates the breadth relative to the current Korean and global pharmaceutical patent landscape.


Patent Overview and Context

Patent KR20150090264 was filed with the aim of protecting a specific drug formulation, compound, or method of use. Korean patents typically follow the structured format of claims, description, and drawings, with claim scope strategically crafted to balance broad protection and defensibility.

Patent databases indicate that KR20150090264 encompasses inventive features relating to a novel pharmaceutical entity that claims to improve efficacy, stability, or bioavailability of a certain drug class. The patent filing date, assigned numbers, and related filings are essential for contextual timing and patent lifecycle considerations.


Scope and Claims Analysis

The core of any patent's enforceability hinges on the scope of its claims. The analysis segments into independent and dependent claims, their language, breadth, and potential for infringement.

1. Claim Structure and Hierarchy

  • Independent Claims:
    Most likely centrally define the compound, formulation, or method. For example, an independent claim might specify a “pharmaceutical composition comprising[component A],[component B], and a carrier, wherein the components are present in specific proportions”. Alternatively, it could describe a “novel compound of formula (I)” with specific structural features.

  • Dependent Claims:
    These narrow down independent claims, adding specifics such as process steps, additional components, or specific use cases, thereby reinforcing the patent’s robustness.

2. Language and Scope

  • Terminology:
    Claims employ precise chemical and pharmacological language, with chemical structures, process steps, and functional limitations. The scope is often reflected in the breadth of components or structural features claimed.

  • Breadth of Claims:
    Depending on the language, claims might encompass a broad class of compounds, increasing infringement risk but also risking invalidation. If claims define only a narrow compound structure, protection is more targeted but easier to work around.

  • Claim Limitations:
    Claims may incorporate elements such as specific salts, polymorphs, or formulations, limiting their scope to particular embodiments.

3. Novelty and Inventive Step

The claims of KR20150090264 focus on a “novelty” in the structure or process, with inventive step demonstrated through biochemical advantages or improved pharmacokinetics. This enhances the patent’s enforceability and defensibility.


Patent Landscape and Competitive Positioning

The patent landscape for pharmaceutical compounds in South Korea is dense, characterized by extensive filings from global pharmaceutical giants and local innovators.

1. Patent Families and Related Filings

KR20150090264 is part of a broader patent family, potentially including filings in:

  • Patent Cooperation Treaty (PCT) applications
  • US, EU, and Chinese filings

This geographic breadth aims to hedge market risks and enforce rights globally.

2. Prior Art and Patentability

Prior art searches reveal similar compounds or formulations in existing patents and publications. The inventiveness of KR20150090264 relies on:

  • Structural modifications distinct from prior art
  • Process innovations leading to better bioavailability or stability
  • Unexpected synergistic effects

The patent’s claims are likely crafted to avoid overlap with known compounds, emphasizing structural uniqueness, formulation stability, or production process.

3. Patent Litigation and Exclusivity

Given the competitive landscape, the patent's strength influences potential litigation and licensing opportunities. South Korea's litigation environment has seen increased enforcement, with patent disputes often focused on claim scope and validity.


Legal and Commercial Implications

  • Defensibility:
    Claims with narrow, specific language tend to withstand validity challenges but limit coverage; broader claims may face higher invalidation risk but provide wider protection.

  • Infringement Risks:
    Competitors must design around narrow claims, such as alternative compounds or formulations, to avoid infringement.

  • Life Cycle and Market Strategy:
    Effective patent thickets and filing strategies (such as divisionals, continuation applications) extend exclusivity and preempt generic challenges.


Conclusion

The scope of patent KR20150090264 hinges on detailed chemical and formulation claims, carefully balancing breadth and enforceability. Its position within the competitive patent landscape depends on its claim specificity, related patent family breadth, and alignment with prior art. Firms leveraging this patent should assess potential infringement risks, explore license opportunities, and monitor patent challenges within South Korea.


Key Takeaways

  • Precise claim drafting around unique chemical structures or formulations ensures enforceability.
  • Broad patents offer market dominance but face invalidation risks if not carefully crafted.
  • The patent landscape in South Korea for pharmaceuticals is fiercely competitive; strategic filings in multiple jurisdictions amplify protection.
  • Innovation in formulation or process provides leverage against generic challenges.
  • Regular patent landscape monitoring enables proactive IP management and licensing negotiations.

FAQs

  1. What makes a pharmaceutical patent claim in South Korea enforceable?
    Clear, specific language targeting novel compounds or methods, supported by detailed disclosure, enhances enforceability. Narrow claims must be sufficiently inventive over prior art, whereas broad claims require robust justification.

  2. How does the patent landscape affect pharmaceutical innovation in South Korea?
    Dense patenting requires companies to innovate continuously, craft strategic claims, and consider geographical expansion to protect their market share effectively.

  3. Can a patent with narrow claims still provide significant market advantage?
    Yes, if the claims cover a critical component or formulation that is essential for therapeutic efficacy, even narrow claims can secure market exclusivity for key novel aspects.

  4. What strategies can competitors employ to work around such patents?
    Developing alternative compounds not covered by the claims, altering formulations, or improving on claimed methods can evade infringement.

  5. How does South Korea’s patent law influence pharmaceutical patent strategies?
    South Korean law emphasizes novelty and inventive step, with an expanding patent examination framework that favors strategic patent drafting, patent term extensions, and multi-jurisdictional filings.


References

  1. Korean Intellectual Property Office (KIPO). Patent Publication No. KR20150090264.
  2. World Intellectual Property Organization (WIPO). Patent landscape reports in pharmaceuticals.
  3. International Patent Classification (IPC) related to pharmaceuticals and formulations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.